CNCR

Loncar Cancer Immunotherapy ETF

Up$20.60
+$0.16
(+0.78%)
As of 12:00:00 AM EDT | 5/24/19  |  Market Closed

CNCR Trading Data

Open

$20.51

Low Price

$20.51

High Price

$20.7

Previous Last Price

$20.44

Bid Size

$0 X 0

Ask Size

$0 X 0

CNCR Portfolio Data

AUM

$37,851,000

Shares

1,850

PE Ratio

15

Price / Book Ratio

2.72

Expense Ratio

0.79

Net Asset Value

$20.46

Volume

Volume

5,000

Avg. Volume (YDT)

10,366

Dollar Volume

$47,989

Weekly Avg. Volume

5,040

Monthly Avg. Volume

7,855

Quarterly Avg. Volume

8,734

CNCR Fund Description

The Loncar Cancer Immunotherapy ETF seeks investment results that correspond generally to the price and yield per for mance, before fees and expenses, of the Loncar Cancer Immunotherapy Index.

CNCR Chart

CNCR Summary

Fund Family

Exchange Traded Concepts

Tracks This Index

Loncar Cancer Immunotherapy ETF

Inception Date

2015-10-15

Asset Class

Equity

Asset Class Size

Biotech

CNCR Classification

Region (General)

Global

Region (Specific)

Sector

Health Care

Equity Index

Leveraged Family

CNCR Holdings

Top 10 Holdings

Loncar Cancer Immunotherapy ETF (CNCR)
0%
%
%
%
%
%
%
%
%
%

Total CNCR Holdings

Total Holdings: 1

Loncar Cancer Immunotherapy ETF (CNCR)
0%

CNCR Technicals

Alpha

-12.56

Beta

1.9

Leverage

Long

Standard Deviation

2.65

CNCR Dividends

Dividend Date

2017-12-28

Latest Dividend

0.35

Annual Dividend

0

Annual Dividend Rate

0

Annual Dividend Yield

1.0E-5

CNCR Performance

YTD Return

9.17%

1 Year Return

-27.16%

3 Year Return

-10.75%

5 Year Return

0%

10 Year Return

-25.5%

CNCR Related Articles

ETF Performance Report: October

ETF Performance Report: October

The equities market and stock exchange traded funds ended October flat in muted action as a renewed FBI investigation into…